Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Strata Critical Medical (SRTA) and Old Dominion Freight (ODFL)

Tipranks - Fri Mar 6, 12:22AM CST

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Strata Critical Medical (SRTAResearch Report) and Old Dominion Freight (ODFLResearch Report).

Claim 70% Off TipRanks Premium

Strata Critical Medical (SRTA)

Ladenburg Thalmann & Co. analyst Jon Hickman reiterated a Buy rating on Strata Critical Medical yesterday and set a price target of $11.25. The company’s shares closed last Wednesday at $4.89, close to its 52-week high of $5.17.

Hickman has an average return of 2.7% when recommending Strata Critical Medical. ;'>

According to TipRanks.com, Hickman is ranked #2226 out of 12134 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Strata Critical Medical with a $9.63 average price target, a 98.6% upside from current levels. In a report released yesterday, Lake Street also maintained a Buy rating on the stock with a $8.00 price target.

See today’s best-performing stocks on TipRanks >>

Old Dominion Freight (ODFL)

Wells Fargo analyst Christian Wetherbee maintained a Sell rating on Old Dominion Freight yesterday and set a price target of $165.00. The company’s shares closed last Wednesday at $216.19.

According to TipRanks.com, Wetherbee is a 5-star analyst with an average return of 15.4% and a 62.7% success rate. Wetherbee covers the Industrial Goods sector, focusing on stocks such as Canadian Pacific Kansas City, Canadian National Railway, and United Airlines Holdings. ;'>

Old Dominion Freight has an analyst consensus of Hold, with a price target consensus of $201.16.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.